The European ADHD Guidelines Group replies

Autor: Samuele Cortese, Daniel Brandeis, Martin Holtmann, Edmund J.S. Sonuga-Barke, Philip Asherson, Tobias Banaschewki, Jan Buitelaar, David Coghill, David Daley, Marina Danckaerts, Ralf W. Dittmann, Manfred Doepfner, Maite Ferrin, Chris Hollis, Eric Konofal, Michel Lecendreux, Aribert Rothenberger, Paramala Santosh, Emily Simonoff, César Soutullo, Hans-Christoph Steinhausen, Argyris Stringaris, Eric Taylor, Saskia Van der Oord, Ian Wong, Alessandro Zuddas
Přispěvatelé: Danckaerts, Marina
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Zdroj: Journal of the American Academy of Child and Adolescent Psychiatry, 55, 1092-1093
Journal of the American Academy of Child and Adolescent Psychiatry, 55, 12, pp. 1092-1093
ISSN: 0890-8567
Popis: Dr. Micoulaud-Franchi et al. raise concerns relating to our 2016 meta-analysis1 of neurofeedback as a treatment for attention-deficit/hyperactivity disorder (ADHD). It is encouraging that Dr. Micoulaud-Franchi et al. agree with us that there is “an urgent need to conduct future research that associates both high quality of [randomized controlled trial] RCT and high quality of [electroencephalography] EEG-neurofeedback sessions.” Consistent with this, we wrote, “Future efforts should focus on implementing standard neurofeedback protocols, ensuring learning, and optimizing clinically relevant transfer.”1(p444) This is in line with the significant advantage for neurofeedback demonstrated in our additional preliminary analysis of the few studies meeting such standards.
Databáze: OpenAIRE